INIS
reviews
100%
lymphomas
82%
cancer
61%
patients
60%
bones
51%
tumors
42%
blood
37%
metastases
34%
tissues
32%
carcinomas
30%
kinases
23%
children
23%
men
23%
antibodies
23%
biopsy
22%
liver
20%
kidneys
20%
anemias
20%
thyroid
20%
prostate
20%
fractures
20%
proposals
20%
drugs
20%
monocytes
20%
valves
20%
keratin
20%
pathology
18%
malignancies
18%
diseases
17%
edta
16%
evaluation
15%
ph'chromosome
13%
surgery
13%
correlations
10%
receptors
10%
tumor cells
10%
neoplasms
10%
cytology
10%
effusion
10%
coronaries
10%
aggregation
10%
arteries
10%
fat cells
10%
fibrin
10%
bypasses
10%
levels
9%
mutations
8%
classification
8%
chemotherapy
8%
pain
8%
Medicine and Dentistry
Diagnosis
48%
Case Report
47%
Bone
47%
Patient
28%
Cancer
24%
Lesion
24%
Child
24%
Malignant Neoplasm
24%
Neoplasm
23%
Lymphoma
23%
Hemolytic Anemia
20%
Pathologic Fracture
20%
Non-Hodgkin Lymphoma
20%
Prostate Cancer
20%
Histology
20%
Hemangioendothelioma
20%
Liver Metastasis
20%
Myopathy
20%
Peripheral T-Cell Lymphoma
20%
Pseudothrombocytopenia
20%
Thyroid Gland
20%
Thymoma
20%
Phosphoglycerate Kinase
20%
Flow Cytometry
20%
Neurologic Disease
20%
Soft Tissue
20%
Papillary Thyroid Cancer
20%
Recognition
20%
Mesothelial Cell
20%
Metastatic Carcinoma
17%
Fine-Needle Aspiration
16%
Keratin
13%
Monocyte
13%
Calretinin
13%
Aggressive Lymphoma
13%
Thyroidectomy
12%
Biopsy
11%
Differential Diagnosis
10%
Organ
9%
Evaluation Study
8%
Pathology
8%
Man
8%
Small Cell Sarcoma
8%
Thyroid Tumor
8%
Specimen
8%
Analysis
8%
Examination
8%
Cells
8%
Femur
8%
Fracture
8%
Keyphrases
Diagnostic Components
20%
Novel Variants
20%
Primary non-Hodgkin's Lymphoma
20%
Bone Lymphoma
20%
Variant Translocation
20%
Eosinophilic Myositis
20%
Complex Variants
20%
Leukemic Presentation
20%
Neurological Dysfunction
20%
Type B3 Thymoma
20%
Myopathy
20%
Galveston
20%
Pseudothrombocytopenia
20%
Hemangioendothelioma
20%
Phosphoglycerate Kinase 1 (PGK1)
20%
Hemolytic Anemia
20%
Invasive Urothelial Carcinoma
20%
Mesothelial/monocytic Incidental Cardiac Excrescences
20%
Ph Chromosome
13%
Excrescence
13%
Minimal Change Disease
10%
Atraumatic Fracture
10%
EDTA Blood
8%
Lymphoid Neoplasms
6%
Rapid On-site Evaluation
6%
Follicular Thyroid Lesion
6%
Extranodal NK-T-cell Lymphoma
6%
Tooth Removal
6%
Diffuse Large
6%
Primary Bone Lymphoma
6%
Extra Chromosomes
6%
Aggressive Lymphoma
6%
BCR-ABL1
6%
Eosinophilic Microabscess
6%
Color Image Fusion
6%
ABL1
6%
Three-way Translocation
6%
Abdominal Wall Tumor
6%
Ultrasound-guided Fine-needle Aspiration Cytology
6%
Papillary Intralymphatic Angioendothelioma
6%
Intermediate Malignancy
6%
Polygonal Cells
6%
Atrial Appendage
6%
Mature T-cell Lymphoma
5%
Human Cancer Type
5%
P-MAPK
5%
MET Pathway
5%
Antibody Selection
5%
Lymphocyte Predominant
5%
Phospholipase A2 Receptor (PLA2R)
5%